# Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars

> **NCT00469235** · PHASE1,PHASE2 · COMPLETED · sponsor: **Renovo** · enrollment: 20 (actual)

## Conditions studied

- Keloid

## Interventions

- **DRUG:** Avotermin

## Key facts

- **NCT ID:** NCT00469235
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00469235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00469235, "Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid Scars". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00469235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*